Article Text
Structured abstracts of sentinel articles: Picket
Oral Ivermectin is more effective than topical malathion in difficult-to-treat head lice infestation
Statistics from Altmetric.com
Footnotes
-
Sources of funding The manufacturer of Ivermectin (Johnson & Johnson–Merck Sharp & Dohme-Chibret) funded the trial, was involved in the study design and provided the study medications. A ‘contract research organisation’ collected the data. An industry author was involved in the writing of the manuscript. All but one author received consulting fees from the manufacturer, held stock options in the company or were employed by the manufacturer.
Footnotes
-
Competing interests None.
-
Provenance and peer review Commissioned, internally peer reviewed.